Genes, demography and life span: the contribution of demographic data and genetic studies on ageing and longevity. Am. J. Hum. Genet.

(

),

–

Yen, C.J., Beamer, B.A., Negri, C., Silver, K., Brown, K.A., Yarnall, D.P., Burns, D.K., Roth, J., Shuldiner, A.R.,

Molecular scanning of the human peroxisome proliferator activated receptor gamma (

PAR gamma) gene in diabetic Caucasians: identification of a Pro

Ala PPAR gamma

missense mutation. Biochem. Biophys. Res. Commun.

(

),

–

Zietz, B., Barth, N., Spiegel, D., Schmitz, G., Scholmerich, J., Schaffler, A.,

A Pro

Ala polymorphism in the peroxisome proliferator- activated receptor-gamma

(PPARgamma

) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type

diabetes patients. Exp. Clin. Endocrinol. Diabetes

(

),

–

M. Barbieri et al. / Experimental Gerontology 39 (2004) 1095–1100

The organization, promoter analysis, and expression of the human PPARgamma gene. J. Biol. Chem.

(

),

–

Franceschi, C., Motta, L., Valensin, S., Rapisarda, R., Franzone, A., Berardelli, M., Motta, M., Monti, D., Bonafe`, M., Ferrucci, L., Deiana, L., Pes, G.M., Carru, C., Desole, M.S., Barbi, C., Sartoni, G., Gemelli, C., Lescai, F., Olivieri, F., Marchegiani, F., Cardelli, M., Cavallone, L., Gueresi, P., Cossarizza, A., Troiano, L., Pini, G., Sansoni, P., Passeri, G., Lisa, R., Spazzafumo, L., Amadio, L., Giunta, S., Stecconi, R., Morresi, R., Viticchi, C., Mattace, R., De Benedictis, G., Baggio, G.,

Do men and women follow different trajectories to reach extreme longevity? Aging Clin. Exp. Res.

,

–

Gerkins, V.R., Ting, A., Menck, H.T., Casagrande, J.T., Terasaki, P.I., Pike, M.C., Henderson, B.E.,

HLA heterozygosity as a genetic marker of long term survival. J. Natl Cancer Inst.

,

–

Hasstedt, S.J., Ren, Q.-F., Teng, K., Elbein, S.C.,

Effect of the peroxisome proliferator-activated receptor-

Pro

Ala variant on obesity,glucose homeostasis, and bloodpressurein membersof familial Type

diabetic kindreds. J. Clin. Endocrinol. Metab.

,

–

Ho, W.L., Chang, J.W., Tseng, R.C., Chen, J.T., Chen, C.Y., Jou, Y.S., Wang, Y.C.,

Loss of heterozygosity at loci of candidate tumor suppressor genes in microdissected primary non-small cell lung cancer. Cancer Detect. Prev.

(

),

–

Hsueh, W.A., Law, R.,

The central role of fat and effect of peroxisome proliferator-activated receptor-gamma on progression of insulin resistance and cardiovascular disease. Am. J. Cardiol.

(

A),

J–

J. Ivanova, R., Henon, N., Lepage, V., Charron, D., Vicaut, E., Schachter, F.,

HLA-DR alleles display sex-dependent effects on survival and discriminate between individual and familial longevity. Hum. Mol. Genet.

(

),

–

Kersten, S., Desvergne, B., Wahli, W.,

Roles of PPARs in health and diseases. Nature

,

–

Koch, M., Rett, K., Maerker, E., Volk, A., Haist, K., Deninger, M., Renn, W., Haring, H.U.,

The PPAR

amino acid polymorphism Pro

Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia

,

–

Lemberger, T., Braissant, O., Juge-Aubry, C., Keller, H., Saladin, R., Staels, B., Auwerx, J., Burger, A.G., Meier, C.A., Wahli, W.,

a. PPAR tissue distribution and interactions with other hormone-signaling pathways. Ann. N. Y. Acad. Sci.

,

–

Lemberger, T., Desvergne, B., Wahli, W.,

b. Peroxisome proliferator- activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol.

,

–

Mancini, F.P., Vaccaro, O., Sabatino, L., Tufano, A., Rivellese, A.A., Riccardi, G., Colantuoni, V.,

Pro

Ala substitution in the peroxisome proliferator-activated receptor g

is not associated with type

diabetes. Diabetes

,

–

Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., Turner, R.C.,

Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia

,

–

Meirhaeghe, A., Fajas, L., Helbecque, N., Cottel, D.,

Impact of the peroxisome proliferator activated receptor

Pro

Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int. J. Obes. Relat. Metab. Disord.

,

–

Olefsky, J.M.,

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists. J. Clin. Invest.

(

),

–

Paolisso, G., Gambardella, A., Balbi, V., Ammendola, S., D’Amore, A., Varricchio, M.,

Body composition, body fat distribution and resting metabolic rate in healthy centenarians. Am. J. Clin. Nutr.

,

–

Paolisso, G., Barbieri, M., Bonafe’, M., Franceschi, C.,

Metabolic age remodeling: the lessons from centenarians. Eur. J. Clin. Invest.

(

),

–

Penn, D.J., Damjanovich, K., Potts, W.K.,

MHC heterozygosity confers a selective advantage against multiple-strain infections. Proc. Natl Acad. Sci. USA

(

),

–

Plutzky, J.,

The potential role of peroxisome proliferator-activated receptors on inflammation in type

diabetes mellitus and athero- sclerosis. Am J Cardiol.

(

A),

J–

J. Puca, A.A., Daly, M.J., Brewster, S.J., Matise, T.C., Barrett, J., Shea- Drinkwater, M., Kang, S., Joyce, E., Nicoli, J., Benson, E., Kunkel, L.M., Perls, T.,

A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome

Proc. Natl Acad. Sci. USA

(

),

–

Ricote, M., Li, A.C., Wilson, T.M., Kelly, C.J., Glass, C.K.,

The peroxisome proliferator-activated receptor (PPARgamma) is a negative regulator of macrophage activation. Nature

,

–

Ricote, M., Huang, J.T., Welch, J.S., Glass, C.K.,

The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of mono- cyte/macrophage function. J. Leukoc. Biol.

(

),

–

Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., Kahn, C.R.,

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N. Engl. J. Med.

(

),

–

Rosmond, R., Chagnon, M., Bouchard, C.,